A First Course in Systems Biology

A First Course in Systems Biology

  • Eberhard Voit
  • Melissa L. Kemp
Publisher:Taylor & FrancisISBN 13: 9781040165478ISBN 10: 1040165478

Paperback & Hardcover deals ―

Amazon IndiaGOFlipkart GOSnapdealGOSapnaOnlineGOJain Book AgencyGOBooks Wagon₹6,263Book ChorGOCrosswordGODC BooksGO

e-book & Audiobook deals ―

Amazon India GOGoogle Play Books GOAudible GO

* Price may vary from time to time.

* GO = We're not able to fetch the price (please check manually visiting the website).

Know about the book -

A First Course in Systems Biology is written by Eberhard Voit and published by Taylor & Francis. It's available with International Standard Book Number or ISBN identification 1040165478 (ISBN 10) and 9781040165478 (ISBN 13).

A First Course in Systems Biology, Third Edition is an introduction to the growing field of systems biology for advanced undergraduates and graduate students. Its focus is the design and analysis of computational models and their applications to diverse biomedical phenomena, from simple networks and kinetics to complex pathway systems, signal transduction, personalized medicine, and interacting populations. The book begins with the fundamentals of computational modeling, then reviews features of the molecular inventories that bring biological systems to life and ends with case studies that reflect some of the frontiers in systems biology. In this way, the First Course provides the reader with a comprehensive background and with access to methods for executing standard tasks of biomedical systems analysis, exposure to the modern literature, and a foundation for launching into specialized projects that address biomedical questions with theoretical and computational means. This third edition has been thoroughly updated. It provides an introduction to agent-based and multiscale modeling, a deeper account of biological design principles, and the optimization of metabolic flux distributions. This edition also discusses novel topics of synthetic biology, personalized medicine, and virtual clinical trials that are just emerging on the horizon of this field.